The effects of bilateral adrenalectomy on postnatal development of tyrosine hydroxylase (TH) activity in the superior cervical ganglion were examined in the rat. Adrenalectomy on day 12 blocked further developmental rise of TH activity, while adrenalectomy on day 7 did not affect normal development of enzyme activity when examined on day 12. The effect of adrenalectomy could be reversed by replacement with daily injections of epinephrine, but not by similar replacement with corticosterone. Chronic administration of SKF 64139, a specific inhibitor of adrenal phenylethanolamine N-methyl-transferase activity that depletes circulating epinephrine levels, also led to a cessation of normal development of TH activity. Similar to adrenalectomy, the effect of SKF 64139 could be observed only after 2 weeks of postnatal development. From these data, it appears that after 2 postnatal weeks, further developmental rise of TH activity in the sympathetic ganglion is an epinephrine-dependent process.

Keywords:
Tyrosine hydroxylase, Superior cervical ganglion, Adrenal epinephrine
This content is only available via PDF.
© 1981 S. Karger AG, Basel
1981
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.